Objective
To compare the accuracy of same day therapy-assessment positron emission tomography/computed tomography (PET/CT) and conventional contrast-enhanced CT (CECT) in patients with oropharyngeal squamous cell carcinoma (OPSCC).
Methods
110 patients (95 male and 15 women, mean age 59 years) biopsy-proven OPSCC were evaluated with same day PET/CT and CECT pair scans, as part of follow-up therapy assessment. Scans were performed within 6 months after completion of primary treatment, (median time: 3.1 months, range: 0.5–6 m). PET/CT and CECT scans were retrospectively reviewed for residual primary site disease, and right and left cervical lymph node involvement. Histopathology or 6 month clinical/imaging follow up were used as gold standard. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy were calculated for the primary site and cervical nodal disease.
Results
Of 110 OPSCC patients, 90.9% were HPV positive, 80.8% were stage 4, and 76.4% received chemo-radiation as the primary treatment. The sensitivity, specificity, PPV, NPV and accuracy of PET/CT and CECT were similar in the evaluation of primary cancer site (PET/CT: 75.0, 91.5, 25.0, 99.0 and 90.9, respectively vs CECT: 75.0, 90.6, 23.1, 99.0 and 90.0, respectively). In evaluating cervical lymph node involvement, PET/CT appeared to have higher accuracy (96.8% vs. 81.7%), specificity (97.7% vs. 81.7%) and PPV (45.8% vs. 16.5%), comparable NPV (99.4% for both), and lower sensitivity (65% vs. 75%) as compared to same day CECT.
Conclusion
Same day PET/CT and CECT scans had comparable accuracy in the evaluation of primary tumor sites after completion of therapy in patients with OPSCC. PET/CT showed higher accuracy in the evaluation of cervical lymph node involvement.